Abstract
American Journal of HematologyVolume 83, Issue 10 p. 763-764 CommentaryFree Access Plasmablastic lymphoma: One or more entities?† Antonino Carbone, Corresponding Author Antonino Carbone [email protected] Department of Pathology, National Cancer Institute of Milan, Milan, ItalyDepartment of Pathology, Fondazione IRCCS, Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milano, ItalySearch for more papers by this authorAnnunziata Gloghini, Annunziata Gloghini Department of Pathology, National Cancer Institute of Milan, Milan, ItalySearch for more papers by this author Antonino Carbone, Corresponding Author Antonino Carbone [email protected] Department of Pathology, National Cancer Institute of Milan, Milan, ItalyDepartment of Pathology, Fondazione IRCCS, Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milano, ItalySearch for more papers by this authorAnnunziata Gloghini, Annunziata Gloghini Department of Pathology, National Cancer Institute of Milan, Milan, ItalySearch for more papers by this author First published: 22 July 2008 https://doi.org/10.1002/ajh.21259Citations: 29 † Conflict of Interest: Nothing to report. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 ES Jaffe, NL Harris, H Stein, JW Vardiman, Editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. 2 Delecluse HJ,Anagnostopoulos I,Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 1413– 1420. 3 Castillo J,Pantanowithz L,Dezube BJ. HIV-associated plasmablastic lymphoma: A literature review of 112 cases. Am J Hematol, in press. 4 Nador RG,Cesarman E,Chadburn A, et al. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645– 656. 5 Dupin N,Diss TL,Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95: 1406– 1412. 6 Deloose ST,Smit LA,Pals FT, et al. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005; 19: 851– 855. 7 Carbone A,Gloghini A,Vaccher E, et al. KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects: Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotypes. J Clin Pathol 2005; 58: 1039– 1045. 8 Klein U,Gloghini A. Gaidano G, et al. Gene expression profile analysis of AIDS related primary effusion lymphoma (PEL) suggest a plasmablastic derivation and identifies PEL-specific transcripts. Blood 2003; 101: 4115– 4121. 9 Carbone A,Gloghini A,Larocca LM, et al. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells. Blood 1999; 93: 2319– 2326. 10 Klein U,Dalla-Favera R. Germinal centres: Role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8: 22– 33. 11 Vockerodt M,Morgan S,Kuo M, et al. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. J Pathol, [Epub ahead of print]. 12 Colomo L,Loong F,Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004; 28: 223– 228. 13 Petitjean B,Jardin F,Joly B, et al. Pyothorax-associated lymphoma: A peculiar clinicopathologic entity derived from B-cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 2002; 26: 724– 732. 14 Carbone A,Gloghini A.Vaccher E, et al. Kaposi's sarcoma-associated herpes virus/human herpes virus type 8-positive solid lymphoma. A tissue-based variant of primary effusion lymphoma. J Mol Diagn 2005; 7: 17– 27. Citing Literature Volume83, Issue10October 2008Pages 763-764 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
